Ratio-Based Assessments
Cross-source consensus on Ratio-Based Assessments from 1 sources and 8 claims.
1 sources · 8 claims
How it works
Dosage & preparation
Risks & contraindications
Comparisons
Highlighted claims
- The TyG index is presented as the most accurate currently available clinical proxy for insulin resistance. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- Ratio-based assessments combine volatile markers to partially cancel noise. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- TyG is described as mechanistically grounded because triglycerides and glucose are downstream products of insulin resistance pathophysiology. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- HOMA-IR combines fasting insulin and fasting glucose to reduce the volatility of each input. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- TG:HDL is more stable than HOMA-IR because triglycerides and HDL are less moment-to-moment volatile than fasting insulin. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- HOMA-IR remains used in research, especially PCOS studies, but has been superseded by more stable ratios for primary clinical use. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- A TG:HDL ratio below 2.0 is presented as the current recommended target, replacing the older 3.0 threshold as too permissive. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- A TyG concern threshold of 8.1-8.4 is associated with higher likelihood of diabetes transition, diabetic complications, and major adverse cardiovascular events. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework